Neuroscience Weekly News - October 1st 2025
October 1, 2025ublituximab-xiiy,UnitedHealthcare,Kisunla,BRAF paradox breaker,abbvie,donanemab,Eisai,novartis,Tavapadon,lecanemab,Huntington's disease,Lundbeck,LEQEMBI,BioPharma and Tech News,American Migraine Foundation,D1/D5 agonist,Eli Lilly,Association of Migraine Disorders,Theranica,Biogen,Nira Medical,Pier 88 Health,TG Therapeutics,Century Health,Nerivio,BRIUMVI,CHARM study,Remote Electrical Neuromodulation,AMT-130,Rocky Mountain MS Clinic,Neuroscience News,uniQure,Kyverna Therapeutics,Fore Biotherapeutics,KYV-101,plixorafenib,CD19 CAR-T,Kesimpta,Plus Therapeuticsofatumumab,CNSide CSF assay
🧠 This Week in Neuroscience: Alzheimer’s EC Nod, Huntington’s Breakthrough, MS…
Women's Health Latest News - Sept 17th to Sept 30th
October 1, 2025ER+ HER2– MBC,Mifepristone,telehealth,PrEP,FDA,Women's Health News,astrazeneca,BioPharma and Tech News,Ovarian Cancer,Eli Lilly,HIV prevention,ENHERTU,Daiichi Sankyo,lenacapavir,Inluriyo,ESR1 mutationfam-trastuzumab deruxtecan,T-DM1
Watch Our Video Summary Capturing Top Women's Health News from the Last Two…
Artificial Intelligence and Digital Health News - September 30th 2025
September 30, 2025Philips MCOT ePatch,Sanofi Ventures,BioPharma and Tech News,AI in Healthcare and Digital Health,Neuralink BCI,NHS fetal anomaly AI,Cleerly LABS AI-QCT,PRISM AI radiology,Mayo Clinic pediatric asthma AI,Leukemia ML models,Spren body scan,RhythmScience HF-AI,Clinical AI scribes,iCARE individualized assessments,AI-designed phagesCortical Labs CL1,US AI policy
AI in Healthcare and Digital Health Update: AI Imaging, RCTs, Brain-Computer…
Latest Obesity News - Sept 15th to Sept 29th
September 30, 2025Innovent Biologics mazdutide,Novo Nordisk Wegovy,semaglutide,Eli Lilly Zepbound,pfizer,Eli Lilly Mounjaro,BioPharma and Tech News,Ascletis ASC47,obesity drug development,Obesity News,weight loss,Orforglipron,obesity care,EASD,lanifibranor,Metsera,oral GLP-1,bimagrumabmicrobiome biomarkers,Roche Carmot CT-388
Watch Our Video Summary Capturing Top Obesity News from the Last Two Weeks……
Obesity Weekly News - September 29th 2025
September 30, 2025EASD,microbiome biomarkers,ASC47,EHMSG,wegovy,lanifibranor,pan-PPAR,semaglutide,Metsera,Obesity News,pfizer,MET-097i,roche,MET-233i,BioPharma and Tech News,amylin,Novo Nordisk,CT-388,Mounjaro,Carmot,Zepbound,oral GLP-1,Eli Lilly,Xinermei,mazdutide,API manufacturing,Orforglipron,THRβ agonist,Ascletis,bimagrumab,Innovent Biologics,myostatinGLP-1 RA,ActRIIB pathway
Obesity Update: Pfizer–Metsera Acquisition, Lilly’s $6.5B API Expansion, &…
Endocrinology Weekly Update - September 29th 2025
September 30, 2025Lynkuet,Prolia,elinzanetant,Xgeva,semaglutide,Baricitinib,Dr. Reddy’s,bayer,Olumiant,Alvotech,Taiwan,BANDIT,STOBOCLO,Celltrion,GRADE,OSENVELT,BioPharma and Tech News,RIGHT,Health Canada,Novo Nordisk,Primary hyperparathyroidism,Paltusotine,T2D,parathyroidectomy,PALSONIFY,PCOS,HKUMed,Crinetics,thyroid cancer,Desiccated thyroid extract,SST2 agonist,GLP-1 Receptor Agonists,North Star,DPP-4 inhibitors,EASD,Acella,SLE,diabetes distress guideline,Neuvosyn,lupus nephritis,Kyinsu,Denosumab,Fertility & Sterility,insulin icodecAVT03,Endocrinology News
Endocrinology Update: Once-Weekly Kyinsu, Bayer’s Lynkuet, EASD’s clinical…
Latest Oncology News - Sept 15th to Sept 29th
September 29, 2025BioPharma and Tech News,Rgenta TherapeuticsNuvation Bio,taletrectinib,Deciphera,vimseltinib,adenoid cystic carcinoma,ROS1 positive NSCLC,tenosynovial giant cell tumor,Merck KEYTRUDA,AstraZeneca Enhertu,Oncology News
Watch Our Video Summary Capturing Top Oncology News from the Last Two Weeks…
Oncology Weekly News - September 29th 2025
September 29, 2025IDH2,ESR1 mutation,FG-3180,Fore Biotherapeutics,giredestrant,Bristol Myers Squibb,astrazeneca,plixorafenib,evERA,nivolumab SC,roche,BRAF V600,SERD,INESSS,BioPharma and Tech News,FORTE,everolimus,Quebec,Pancreatic cancer,Ipsen,Alligator Bioscience,Oncology News,Eli Lilly,cabozantinib,mitazalimab,Opdivo,Cabozantinib Ipsen,OPTIMIZE-1,Glioma,CABINET trial,Artios,FibroGen,neuroendocrine tumors,alnodesertib,ENHERTU,trastuzumab deruxtecan,ATR inhibitor,Daiichi Sankyo,pertuzumab,STELLA trial,Servier,DESTINY-Breast09,ATM-negative mCRC,Voranigo,Inluriyo,FG-3246,vorasidenib,imlunestrant,FOR46,IDH1EMBER-3,CD46 ADC
Oncology Update: Vorasidenib Approval, Plixorafenib Efficacy, OPDIVO…
Hematology Weekly News - September 29th 2025
September 29, 2025Heidelberg Pharma,cyclophosphamide,HDP-101,Valoctocogene Roxaparvovec,hemophilia,Kura Oncology,FVIII gene therapy,CRISPR Therapeutics,NPM1-m AML,Azercell,BCMA,KOMET-001,leukemia CSR,Multiple Myeloma,Aptose Biosciences,VarmX,Hemophilia A,AML triplet,VMX-C001,BioPharma and Tech News,OGT,FXa DOAC,Ziftomenib,CytoCell,urgent surgery,Revumenib,KMT2A,Sirius Therapeutics,Tuspetinib,CDx,SRSD107,Thalassemia,Blood Cancer United,FXI siRNA,Hanmi Pharmaceutical,Big Nova Foundation,VTE,Revuforj,pediatric leukemia,Hematology News,Rituximab,acquired hemophilia AKyowa Kirin,corticosteroids
Hematology Update: Advanced HDP-101 Cohort, Pivotal Ziftomenib Data, Pediatric…
ERS 2025 Preview: Key Respiratory Highlights to Watch
September 27, 2025Our Insights,Asthmalung cancer,Sleep Apnea,Bronchiectasis,pulmonary hypertension,chronic obstructive pulmonary disease,Conference Previews,ERS 2025,respiratory science,AI in pulmonology
ERS 2025 at a glance Ahead of ERS 2025 in Amsterdam, get concise highlights…
Vaccines Weekly Update - September 26th 2025
September 26, 2025pulmonary arterial hypertension,respiratory therapeutics,merck,Vaccine news,COPD,BioPharma and Tech News,Idiopathic Pulmonary Fibrosis,Altesa BioSciences,ATyr Pharma,Pulmonary Sarcoidosis,Enanta,Endeavor BioMedicines,PureTech Health,Redx Pharma,AmnealDiagonal Therapeutics,Zymeworks
Vaccine Research Update: KRAS Vaccine Progress, Breast Cancer Milestone,…
Public Health Weekly News - September 26th 2025
September 26, 2025Ebola,World Health Organization,Huntington's disease,syphilis,PDAC,chlamydia,Longevity,gonorrhea,BioPharma and Tech News,American Heart Association,Pancreatic cancer,Public Health News,HIV prevention,hypertension,AMT-130,uniQure,lenacapavir,Gilead Sciences,Gates FoundationHealthy aging,epigenetics
Public Health Update: Huntington’s Gene Therapy, Low-Cost HIV PrEP, New…









